Malignant Ovarian Epithelial Tumor — Trials

Malignant Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

897 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05472857	Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression	unknown	Phase 1	30	Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY	1	Mar 6, 2024	clinicaltrials
NCT05498597	AMT-151 in Patients With Selected Advanced Solid Tumours	unknown	Phase 1	30	Multitude Therapeutics Inc.INDUSTRY	2	Oct 19, 2023	clinicaltrials